When it comes to training artificial intelligence, OpenAI and Babylon Biosciences have shown that experienced hands can help steer the programs toward greater accuracy—through a collabora | The company behind ChatGPT and the biotech startup have been working to tailor models specifically to identify the pitfalls that may cause a promising molecule to miss its primary endpoint, through a process called reinforcement fine-tuning.
With fine-tuned AI models, OpenAI, Babylon aim to predict clinical trial successes
